Literature DB >> 22707719

Rearranging exosites in noncatalytic domains can redirect the substrate specificity of ADAMTS proteases.

Weiqiang Gao1, Jian Zhu, Lisa A Westfield, Elodee A Tuley, Patricia J Anderson, J Evan Sadler.   

Abstract

ADAMTS proteases typically employ some combination of ancillary C-terminal disintegrin-like, thrombospondin-1, cysteine-rich, and spacer domains to bind substrates and facilitate proteolysis by an N-terminal metalloprotease domain. We constructed chimeric proteases and substrates to examine the role of C-terminal domains of ADAMTS13 and ADAMTS5 in the recognition of their physiological cleavage sites in von Willebrand factor (VWF) and aggrecan, respectively. ADAMTS5 cleaves Glu(373)-Ala(374) and Glu(1480)-Gly(1481) bonds in bovine aggrecan but does not cleave VWF. Conversely, ADAMTS13 cleaves the Tyr(1605)-Met(1606) bond of VWF, which is exposed by fluid shear stress but cannot cleave aggrecan. Replacing the thrombospondin-1/cysteine-rich/spacer domains of ADAMTS5 with those of ADAMTS13 conferred the ability to cleave the Glu(1615)-Ile(1616) bond of VWF domain A2 in peptide substrates or VWF multimers that had been sheared; native (unsheared) VWF multimers were resistant. Thus, by recombining exosites, we engineered ADAMTS5 to cleave a new bond in VWF, preserving physiological regulation by fluid shear stress. The results demonstrate that noncatalytic thrombospondin-1/cysteine-rich/spacer domains are principal modifiers of substrate recognition and cleavage by both ADAMTS5 and ADAMTS13. Noncatalytic domains may perform similar functions in other ADAMTS family members.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22707719      PMCID: PMC3411030          DOI: 10.1074/jbc.M112.380535

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  41 in total

1.  Crystal structures of the two major aggrecan degrading enzymes, ADAMTS4 and ADAMTS5.

Authors:  Lidia Mosyak; Katy Georgiadis; Tania Shane; Kristine Svenson; Tracy Hebert; Thomas McDonagh; Stewart Mackie; Stephane Olland; Laura Lin; Xiaotian Zhong; Ronald Kriz; Erica L Reifenberg; Lisa A Collins-Racie; Christopher Corcoran; Bethany Freeman; Richard Zollner; Tod Marvell; Matthew Vera; Phaik-Eng Sum; Edward R Lavallie; Mark Stahl; William Somers
Journal:  Protein Sci       Date:  2007-11-27       Impact factor: 6.725

Review 2.  A disintegrin-like and metalloprotease (reprolysin-type) with thrombospondin type 1 motif (ADAMTS) superfamily: functions and mechanisms.

Authors:  Suneel S Apte
Journal:  J Biol Chem       Date:  2009-09-04       Impact factor: 5.157

3.  Crystal structures of the noncatalytic domains of ADAMTS13 reveal multiple discontinuous exosites for von Willebrand factor.

Authors:  Masashi Akiyama; Soichi Takeda; Koichi Kokame; Junichi Takagi; Toshiyuki Miyata
Journal:  Proc Natl Acad Sci U S A       Date:  2009-10-30       Impact factor: 11.205

4.  Essential role of the disintegrin-like domain in ADAMTS13 function.

Authors:  Rens de Groot; Ajoy Bardhan; Nalisha Ramroop; David A Lane; James T B Crawley
Journal:  Blood       Date:  2009-02-20       Impact factor: 22.113

5.  Characterization of proADAMTS5 processing by proprotein convertases.

Authors:  Jean-Michel Longpré; Daniel R McCulloch; Bon-Hun Koo; J Preston Alexander; Suneel S Apte; Richard Leduc
Journal:  Int J Biochem Cell Biol       Date:  2008-11-01       Impact factor: 5.085

6.  ADAMTS13 cleavage efficiency is altered by mutagenic and, to a lesser extent, polymorphic sequence changes in the A1 and A2 domains of von Willebrand factor.

Authors:  Cynthia M Pruss; Colleen R P Notley; Carol A Hegadorn; Lee A O'Brien; David Lillicrap
Journal:  Br J Haematol       Date:  2008-11       Impact factor: 6.998

7.  Extensive contacts between ADAMTS13 exosites and von Willebrand factor domain A2 contribute to substrate specificity.

Authors:  Weiqiang Gao; Patricia J Anderson; J Evan Sadler
Journal:  Blood       Date:  2008-05-20       Impact factor: 22.113

8.  Structural specializations of A2, a force-sensing domain in the ultralarge vascular protein von Willebrand factor.

Authors:  Qing Zhang; Yan-Feng Zhou; Cheng-Zhong Zhang; Xiaohui Zhang; Chafen Lu; Timothy A Springer
Journal:  Proc Natl Acad Sci U S A       Date:  2009-05-21       Impact factor: 11.205

9.  A novel binding site for ADAMTS13 constitutively exposed on the surface of globular VWF.

Authors:  Sara Zanardelli; Alain C K Chion; Evelyn Groot; Peter J Lenting; Thomas A J McKinnon; Mike A Laffan; Michelle Tseng; David A Lane
Journal:  Blood       Date:  2009-07-08       Impact factor: 22.113

Review 10.  ADAMTS-5: the story so far.

Authors:  A J Fosang; F M Rogerson; C J East; H Stanton
Journal:  Eur Cell Mater       Date:  2008-02-05       Impact factor: 3.942

View more
  15 in total

1.  ADAMTS13 and von Willebrand factor interactions.

Authors:  Catherine B Zander; Wenjing Cao; X Long Zheng
Journal:  Curr Opin Hematol       Date:  2015-09       Impact factor: 3.284

Review 2.  Structure-function and regulation of ADAMTS-13 protease.

Authors:  X L Zheng
Journal:  J Thromb Haemost       Date:  2013-06       Impact factor: 5.824

3.  ADAMTS16 activates latent TGF-β, accentuating fibrosis and dysfunction of the pressure-overloaded heart.

Authors:  Yufeng Yao; Changqing Hu; Qixue Song; Yong Li; Xingwen Da; Yubin Yu; Hui Li; Ian M Clark; Qiuyun Chen; Qing K Wang
Journal:  Cardiovasc Res       Date:  2020-04-01       Impact factor: 10.787

4.  Association of Somatic Mutations of ADAMTS Genes With Chemotherapy Sensitivity and Survival in High-Grade Serous Ovarian Carcinoma.

Authors:  Yuexin Liu; Maya Yasukawa; Kexin Chen; Limei Hu; Russell R Broaddus; Li Ding; Elaine R Mardis; Paul Spellman; Douglas A Levine; Gordon B Mills; Ilya Shmulevich; Anil K Sood; Wei Zhang
Journal:  JAMA Oncol       Date:  2015-07       Impact factor: 31.777

Review 5.  Matrix metalloproteinases as therapeutic targets for idiopathic pulmonary fibrosis.

Authors:  Vanessa J Craig; Li Zhang; James S Hagood; Caroline A Owen
Journal:  Am J Respir Cell Mol Biol       Date:  2015-11       Impact factor: 6.914

Review 6.  From Loci to Biology: Functional Genomics of Genome-Wide Association for Coronary Disease.

Authors:  Sylvia T Nurnberg; Hanrui Zhang; Nicholas J Hand; Robert C Bauer; Danish Saleheen; Muredach P Reilly; Daniel J Rader
Journal:  Circ Res       Date:  2016-02-19       Impact factor: 17.367

7.  Knockout of Adamts7, a novel coronary artery disease locus in humans, reduces atherosclerosis in mice.

Authors:  Daniel J Rader; Muredach P Reilly; Robert C Bauer; Junichiro Tohyama; Jian Cui; Lan Cheng; Jifu Yang; Xuan Zhang; Kristy Ou; Georgios K Paschos; X Long Zheng; Michael S Parmacek
Journal:  Circulation       Date:  2015-02-20       Impact factor: 29.690

8.  Structural basis for the sheddase function of human meprin β metalloproteinase at the plasma membrane.

Authors:  Joan L Arolas; Claudia Broder; Tamara Jefferson; Tibisay Guevara; Erwin E Sterchi; Wolfram Bode; Walter Stöcker; Christoph Becker-Pauly; F Xavier Gomis-Rüth
Journal:  Proc Natl Acad Sci U S A       Date:  2012-09-17       Impact factor: 11.205

9.  Targeted disruption of Adamts16 gene in a rat genetic model of hypertension.

Authors:  Kathirvel Gopalakrishnan; Sivarajan Kumarasamy; Shakila Abdul-Majeed; Andrea L Kalinoski; Eric E Morgan; Amira F Gohara; Surya M Nauli; Wanda E Filipiak; Thomas L Saunders; Bina Joe
Journal:  Proc Natl Acad Sci U S A       Date:  2012-11-26       Impact factor: 11.205

Review 10.  Regulation of ADAMTS Proteases.

Authors:  Keron W J Rose; Nandaraj Taye; Stylianos Z Karoulias; Dirk Hubmacher
Journal:  Front Mol Biosci       Date:  2021-06-29
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.